Zhuzhou, China · Founded 2017 · Privately Held (backing)
Developer of peptide-leading drugs intended to serve the medical sector in China. PepLib is based in Zhuzhou, China and was founded in 2017. Its last reported valuation was $86.1 million in Jul 2019. It has raised $62.1 million.
Last reported valuation
$86.1M
Oct 2026
Priced at
—
Total raised
$62.1M
Last round
—
Cap table — not yet on record
PepLib's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of PepLib with a free account
·The complete investor list: 16 names
·Watch PepLib: the Monday email on marks, rounds and moves
